Communicating genetic risk information for common disorders in the era of genomic medicine.
about
Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq ConsortiumGenetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plansIncorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial)Public preferences for communicating personal genomic risk information: a focus group studyIntegrating big data and actionable health coaching to optimize wellness.Incorporation of personal single nucleotide polymorphism (SNP) data into a national level electronic health record for disease risk assessment, part 1: an overview of requirements.Impact of delivery models on understanding genomic risk for type 2 diabetesDesign and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease.Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) Family Study: rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives.Living laboratory: whole-genome sequencing as a learning healthcare enterprise.Disclosing Secondary Findings from Pediatric Sequencing to Families: Considering the "Benefit to Families"APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.How can psychological science inform research about genetic counseling for clinical genomic sequencing?Participants and Study Decliners' Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing.Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics StudyManagement of incidental findings in clinical genomic sequencingCSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.My46: a Web-based tool for self-guided management of genomic test results in research and clinical settingsGenomic-based tools for the risk assessment, management, and prevention of type 2 diabetes.Obesity Genes, Personalized Medicine, and Public Health Policy.Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience.Patients' perceptions of their relatives' risk of developing rheumatoid arthritis and of the potential for risk communication, prediction and modulation.Communication of Psychiatric Risk in 22q11.2 Deletion Syndrome: A Pilot Project.Genetic risk models: Influence of model size on risk estimates and precision.Disclosing Genetic Risk for Coronary Heart Disease: Attitudes Toward Personal Information in Health Records.Ethical considerations surrounding germline next-generation sequencing of children with cancer.Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysis.When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.Disclosure of personalized rheumatoid arthritis risk using genetics, biomarkers, and lifestyle factors to motivate health behavior improvements:A randomized controlled trial.Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research Study.Ethical issues in neurogenetics.Parents' Experience with Pediatric Microarray: Transferrable Lessons in the Era of Genomic Counseling.Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports.GenIO: a phenotype-genotype analysis web server for clinical genomics of rare diseases.Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing.Effectiveness of a web-based personalized rheumatoid arthritis risk tool with or without a health educator for knowledge of RA risk factors.Management of Incidental Findings in Clinical Genomic Sequencing.
P2860
Q26749580-08BFD710-20A1-4B10-B733-9E06B61DB162Q26801647-DB5B9016-B2AB-4B76-B752-4D469FF38CEBQ30731532-9A21F7DE-79D7-4912-9AF5-2EA8C9E8815AQ30830961-69989095-6BEB-4A69-A2FE-3B9489C13A87Q30883819-354452CC-F1F3-4E82-B494-991BACE82C96Q30884931-08CCD361-A121-424F-9B24-324089A9079FQ33637558-1B371CE2-8374-4EA9-9F5C-07A7B5702EECQ33732477-DE99CDE0-6D01-4269-9434-8CA41A047A2BQ33841435-D3D9E06B-4618-4377-B1A8-B273042A6E67Q34244089-4FBCA429-EC11-4B45-BEEE-917CC4202552Q34995956-A11E0F73-3027-4E49-8C9D-1CFE504BED3AQ36197003-D0AEB05E-9388-4CEC-A3B3-6B55FF16CD6FQ36316285-C9259AE8-4E33-4638-8400-1AB846C84BD8Q36649146-2A1FDE44-7B2A-407E-8F49-7745BDCFFCE1Q36828474-88DB1F0F-FC15-4F65-9E14-412514BF8EDAQ36885357-62B6C544-3558-4A99-AFEE-AB2F724AB518Q37050375-191D1F83-36D4-4FB7-8DAA-3F15061A5A94Q37148891-E0A97B59-74C0-4CB7-9465-9A4F74C7D6D8Q37229202-9E048897-A5F4-4272-A94F-702316B8DB42Q37702883-D959A936-59EB-4514-8629-290B63984A13Q38327711-A454E4B6-20B9-4C36-97F5-9EC2FF6C235DQ38655971-EC8DCAE5-A946-441E-9A80-AD1BF91717B6Q38739043-3F5A67EB-C16C-41E1-B480-18040C2BE44FQ38780133-9129B79B-F2C7-4B07-9EDD-2E625CCC5EC4Q38941809-18297B4C-50E1-4E74-B01D-7558F59F51ACQ38961006-30D69713-E9F5-489B-8EF4-5E0EE0808D5BQ39035132-A3FC279D-A83E-4610-B556-14B07347BCB3Q39235246-D1D48FFC-1222-49D9-9F74-8BC92606805FQ39406228-37C7FCB1-95FD-4DE1-9671-451E62536774Q47294616-5D524260-2576-40B9-9CEF-5634E6DB490CQ47314784-8C1D271A-6F9D-47F2-A889-974A61BC98A3Q47379454-270071AF-DB02-4D8B-810A-3A720B0D5291Q47560820-7FDD7B8A-3961-4421-82CD-7809ED244458Q47564559-E0D43EA6-5DFE-4D7B-B9BA-04634BE69EFAQ47815087-28D2A41C-5FE3-4C03-BC02-C008D7E01756Q48157087-F53305C5-5777-46EA-A556-9A4AF563D7A7Q49333335-659CF9D8-96B0-4AFE-B507-78623C899278Q49825991-24F88475-61CB-4627-9FF7-96564F7AEFA1Q50117154-2321115D-71FA-4DA4-B8DB-D181DC45BA06Q50243039-4540F84E-5D19-438D-B6F1-154C09573DB2
P2860
Communicating genetic risk information for common disorders in the era of genomic medicine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Communicating genetic risk inf ...... n the era of genomic medicine.
@en
Communicating genetic risk inf ...... n the era of genomic medicine.
@nl
type
label
Communicating genetic risk inf ...... n the era of genomic medicine.
@en
Communicating genetic risk inf ...... n the era of genomic medicine.
@nl
prefLabel
Communicating genetic risk inf ...... n the era of genomic medicine.
@en
Communicating genetic risk inf ...... n the era of genomic medicine.
@nl
P2860
P50
P1476
Communicating genetic risk inf ...... n the era of genomic medicine.
@en
P2093
Denise M Lautenbach
P2860
P304
P356
10.1146/ANNUREV-GENOM-092010-110722
P577
2013-01-01T00:00:00Z